| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/19/2015 | US20150050306 Epitope-Scaffold Immunogens Against Respiratory Syncytial Virus (RSV) |
| 02/19/2015 | US20150050305 Hendra and nipah virus g glycoprotein immunogenic compositions |
| 02/19/2015 | US20150050304 CD4+ T Survivin Epitopes and Uses Thereof |
| 02/19/2015 | US20150050302 Artificial nucleic acid molecules comprising a 5'top utr |
| 02/19/2015 | US20150050301 Contiguous Overlapping Peptides for Treatment of House Dust Mites Allergy |
| 02/19/2015 | US20150050300 Disease prevention and alleviation by human myoblast transplantation |
| 02/19/2015 | US20150050297 Use of a glycosylated-modified tetrafunctional non-ionic amphiphilic block copolymer as immune adjuvant |
| 02/19/2015 | US20150050295 Novel lipids and compositions for intracellular delivery of biologically active compounds |
| 02/19/2015 | US20150050294 Methods for diagnosing and treating neuroendocrine cancer |
| 02/19/2015 | US20150050293 Flagellum and anti-flagellum antibody levels in samples as a diagnostic biomarker and therapeutic target for metabolic syndrome |
| 02/19/2015 | US20150050289 Muscle specific receptor kinase and modulation thereof |
| 02/19/2015 | US20150050288 Treatment of TH17-Mediated Autoimmune Disease Via Inhibition of Stat3 |
| 02/19/2015 | US20150050285 Combination Therapy for Cancer Using HSP27 Inhibitor and EGFR Tyrosine Kinase Inhibitors or Anti-Folates |
| 02/19/2015 | US20150050283 Pharmaceutical composition for treatment and/or prevention of cancer |
| 02/19/2015 | US20150050280 Soluble human m-csf receptor and uses thereof |
| 02/19/2015 | US20150050277 Compositions and methods for treating ocular diseases |
| 02/19/2015 | US20150050275 Purification of anti-c-met antibodies |
| 02/19/2015 | US20150050272 Method of dynamic spectroscopy under physiological conditions |
| 02/19/2015 | US20150050240 Treatment of fibrosis |
| 02/19/2015 | US20150050238 Treatment of osteoarthritis and pain |
| 02/19/2015 | US20150050215 Protein-based therapy and diagnosis of tau-mediated pathology in alzheimer's disease |
| 02/18/2015 | EP2837685A1 Anti-fgfr2 antibody |
| 02/18/2015 | EP2837637A1 Novel anti-FcyRIIB IgG-type antibody |
| 02/18/2015 | EP2837388A1 Compositions and methods for antibodies targeting complement protein C5 |
| 02/18/2015 | EP2837387A1 Anticancer agent |
| 02/18/2015 | EP2837386A1 Detoxified Escherichia coli immunogens |
| 02/18/2015 | EP2837373A1 Novel hyaluronic acid decomposition-promoting factor and inhibitor thereof |
| 02/18/2015 | EP2836514A1 Tiki inhibitors |
| 02/18/2015 | EP2836507A2 Sortase- modified vhh domains and uses thereof |
| 02/18/2015 | EP2836231A1 Genetically stable live attenuated respiratory syncytial virus vaccine and its production |
| 02/18/2015 | EP2836230A1 Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same |
| 02/18/2015 | EP2836229A1 Liposomes containing oligopeptide fragments of myelin basic protein, a pharmaceutical composition and a method for treatment of multiple sclerosis |
| 02/18/2015 | EP2591799A9 Cancer peptide vaccine |
| 02/17/2015 | US8957195 Anti-CD19 antibodies with reduced immunogenicity |
| 02/17/2015 | US8957194 1B20 PCSK9 antagonists |
| 02/17/2015 | US8957192 Human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1 |
| 02/17/2015 | US8957047 GLA monotherapy for use in cancer treatment |
| 02/17/2015 | US8957029 Peptide for determining actin structures in living cells |
| 02/17/2015 | US8957019 Oligopeptide for treating liver fibrosis and/or treating hepatitis B and/or improving liver function |
| 02/17/2015 | US8956878 Polypeptides with affinity for heat shock proteins (HSPS) and HSP associated complexes (HACS) and their use in diagnosis and therapy |
| 02/17/2015 | US8956849 Compositions and methods of enhancing immune responses to Eimeria |
| 02/17/2015 | US8956831 Nucleic acids encoding a human monoclonal antibody that specifically binds to IL-1α |
| 02/17/2015 | US8956824 Methods for identifying allosteric modulators of ship polypeptides |
| 02/17/2015 | US8956812 Process for the preparation and purification of recombinant proteins |
| 02/17/2015 | US8956811 Diagnosis of malignant neoplasms using anti-Notch3 antibodies |
| 02/17/2015 | US8956628 Bacteriophage preparations and method of use thereof |
| 02/17/2015 | US8956627 Method of inducing antibodies to human immunodeficiency virus involving the administration of MPER peptide-liposome conjugates |
| 02/17/2015 | US8956626 Modified viral strains and method for improving the production of vaccine seeds of influenza virus |
| 02/17/2015 | US8956625 Inactivated polio vaccines |
| 02/17/2015 | US8956623 Recombinant fusion interferon for animals |
| 02/17/2015 | US8956621 Compositions and methods for treatment of cervical dysplasia |
| 02/17/2015 | US8956620 Anti-HIV vaccine constructed based on amino acid mutations in attenuated live EIAV vaccine |
| 02/17/2015 | US8956619 Soluble CD80 as a therapeutic to reverse immune supression in cancer patients |
| 02/17/2015 | US8956618 Vaccine vectors and methods of enhancing immune responses |
| 02/17/2015 | US8956617 Vaccination by transcutaneous targeting |
| 02/17/2015 | US8956616 Constructs binding to phosphatidylserine and their use in disease treatment |
| 02/17/2015 | US8956615 Methods of treating OX40 mediated recall immune responses using OX40L antibodies and agents useful for identifying same |
| 02/17/2015 | US8956614 BACE1 inhibitory antibodies |
| 02/17/2015 | US8956613 Gemcitabine prodrugs and uses thereof |
| 02/17/2015 | US8956612 Peptide associated with rheumatic fever (PARF) and its use as a diagnostic marker |
| 02/17/2015 | US8956611 Combination of BLyS inhibition and anti-CD 20 agents for treatment of autoimmune disease |
| 02/17/2015 | US8956609 Roles for Dual Endothelin-1/Angiotensin II Receptor (Dear) in hypertension and angiogenesis |
| 02/17/2015 | US8956608 Method for treating sarcopenia using antagonist antibodies against GDF-8 |
| 02/17/2015 | US8956607 Humanized anti-IL 10 antibodies for the treatment of systemic lupus erythematosus (SLE) |
| 02/17/2015 | US8956604 Conjugates comprising an N-oxime bond and associated methods |
| 02/17/2015 | CA2776522C Development of a preventive vaccine for filovirus infection in primates |
| 02/17/2015 | CA2636129C Detection of soluble adiponectin receptor peptides and use in diagnostics and therapeutics |
| 02/17/2015 | CA2635623C Anti-cd19 antibodies with reduced immunogenicity |
| 02/17/2015 | CA2583061C Antibody production method |
| 02/17/2015 | CA2541006C Tim-3 polypeptides |
| 02/17/2015 | CA2485999C Mucosal combination vaccines for bacterial meningitis |
| 02/17/2015 | CA2385745C Methods of administering anti-tnf.alpha. antibodies |
| 02/12/2015 | WO2015021444A1 Combination of ifn-gamma with anti-erbb antibody for the treatment of cancers |
| 02/12/2015 | WO2015021409A1 Compositions and methods relating to c5l2 |
| 02/12/2015 | WO2015021291A2 Antibodies to acetylated cyclophilin and use thereof |
| 02/12/2015 | WO2015021190A1 Comparing the structures of two biomolecules |
| 02/12/2015 | WO2015021155A1 Methods of treatment of hpv related diseases |
| 02/12/2015 | WO2015021147A1 Acid-resistant, attenuated microbial vector for improved oral delivery of multiple targeted antigens |
| 02/12/2015 | WO2015021089A1 Bi-specific monovalent fc diabodies that are capable of binding cd32b and cd79b and uses thereof |
| 02/12/2015 | WO2015020982A2 Direct application system and method for the delivery of bioactive compositions and formulations |
| 02/12/2015 | WO2015020913A2 Influenza hemagglutinin proteins and methods of thereof |
| 02/12/2015 | WO2015020212A1 Pharmaceutical composition for treatment and/or prevention of cancer |
| 02/12/2015 | WO2015020193A1 Novel anti-human tslp receptor antibody |
| 02/12/2015 | WO2015019347A1 Girk as a therapeutic target of immune disorders and a marker of b cell subtypes |
| 02/12/2015 | WO2015019302A2 Peptides |
| 02/12/2015 | WO2015019253A2 Anti-dengue virus genetic vaccine based on the envelope protein ectodomains |
| 02/12/2015 | WO2015019230A1 Bag3 receptor binding molecules for use as a medicament |
| 02/12/2015 | WO2015018831A1 Ligase e3 rnf185 inhibitors and uses thereof |
| 02/12/2015 | WO2015018806A1 Combination immunogenic compositions |
| 02/12/2015 | WO2015018805A1 Novel immunotherapy against several tumors, such as lung cancer, including nsclc |
| 02/12/2015 | WO2015018753A1 Saccharide vaccine formulation |
| 02/12/2015 | WO2015018529A1 Combined pharmaceutical composition |
| 02/12/2015 | WO2015018527A1 ANTIBODY BINDING SITES SPECIFIC FOR EGFRvIII |
| 02/12/2015 | WO2015018421A1 Antibodies, compounds and derivatives thereof for use in the treatment of male infertility |
| 02/12/2015 | WO2015018375A1 Depression regulatory factor and applications thereof |
| 02/12/2015 | WO2015018331A1 Minicircle dna recombinant parental plasmid having genetically engineered antibody gene expression cassette, a minicircle dna having the expression cassette, and applications |
| 02/12/2015 | WO2015017900A1 An antibody therapy for amyloid beta disease |
| 02/12/2015 | WO2014151403A9 Method and apparatus for boosting vaccine efficacy |
| 02/12/2015 | US20150045536 Universal carrier for targeting molecules to gb3 receptor expressing cells |
| 02/12/2015 | US20150044279 Methods and compositions for enhancing immune response |